Theradaptive Inc.

Frederick, MD

UEI
DN45N68LM8M6
CAGE
7AQS5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Veteran Owned Business
  • Hispanic American Owned
  • Service Disabled Veteran Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
7495 New Horizon Way Unit 240, Frederick, MD 21703, USA
Website
theradaptive.com
Founded
2017
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
59 Miscellaneous Retail
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Theradaptive Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Clinical study of sustained-release implant for trauma repair Grant · HT94252310693 Defense Health Agency $7,408,939
Sustained release therapeutic for extremity trauma repair Grant · W81XWH2210875 Medical Command $3,979,465
Tethered recombinant human BMP2 delivered with beta-tricalcium phosphate nanoparticles for the treatment of open… Grant · W81XWH2010305 Defense Health Agency $2,999,976
Award of theradaptive, INC.'s DHA sbir phase II enhancement medical r & d contract for "conformable osteochondral repair… Contract · W81XWH20C0069 Medical Command $549,031
DHA 2016.3 sbir phase II under proposal H2-0278. Contract · W81XWH18C0325 Medical Command $999,825

About Theradaptive Inc.

Theradaptive Inc. is an innovative company developing a therapeutic delivery platform for multiple clinical indications including orthopedic repair. Through federal contract and grant awards, Theradaptive provides research, development, and clinical services related to conformable scaffolds, sustained-release implants, and other regenerative medicine technologies.

Theradaptive has been awarded a $549,031 firm fixed price definitive contract by the Defense Health Agency to support Phase II Enhancement of an SBIR project titled "Conformable Osteochondral Repair Platforms for Prevention of Post Traumatic Osteoarthritis." This contract, set aside for total small businesses, funds continued R&D over 15 months on conformable scaffolds to repair cartilage and bone damage from trauma. As a subcontractor, Theradaptive is also evaluating technologies to render orthopedic implants biologically active through a contract between the Geneva Foundation and prime contractor.

Through the Military Medical Research and Development program, Theradaptive has received Project Grant awards from both the Defense Health Agency and Department of the Army Medical Command supporting clinical research and development of sustained-release therapeutics for trauma repair. A $619,439 award is funding a clinical study investigating an implant to facilitate tissue regeneration in trauma patients. Another $3,979,465 award over two years is enabling preclinical and clinical validation of a therapeutic for extremity trauma repair to advance battlefield medicine. Theradaptive previously partnered as a subgrantee on an award focused on engineered tissue storage and transport.

Quick answers

What is Theradaptive Inc.'s UEI?

Theradaptive Inc.'s Unique Entity ID (UEI) in SAM.gov is DN45N68LM8M6.

What is Theradaptive Inc.'s CAGE code?

Theradaptive Inc.'s CAGE code is 7AQS5.

What is Theradaptive Inc.'s primary NAICS code?

Theradaptive Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Theradaptive Inc. located?

Theradaptive Inc.'s physical address in SAM.gov is 7495 New Horizon Way Unit 240, Frederick, MD 21703, USA.

Is Theradaptive Inc. registered in SAM.gov?

Yes. Theradaptive Inc.'s SAM.gov registration is active through March 30, 2027.

What is Theradaptive Inc.'s most recent federal award?

Theradaptive Inc.'s most recent federal grant award is Clinical study of sustained-release implant for trauma repair (HT94252310693), from Defense Health Agency, on August 1, 2023.

On GovTribe

See Theradaptive Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors